These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16827635)

  • 1. Immunosuppressive strategies in organ transplantation in the light of innate immunity.
    Land WG
    Exp Clin Transplant; 2006 Jun; 4(1):406-15. PubMed ID: 16827635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immunity-mediated allograft rejection and strategies to prevent it.
    Land WG
    Transplant Proc; 2007 Apr; 39(3):667-72. PubMed ID: 17445569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs?
    Land WG; Gutmann T; Daar AS
    Acta Chir Belg; 2008; 108(1):73-82. PubMed ID: 18411578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression in organ transplantation.
    Jordan SC; Rosenthal P; Makowka L
    Semin Pediatr Surg; 1993 Nov; 2(4):206-7. PubMed ID: 8062042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of innate immunity in organ transplantation part III: the quest for transplant tolerance via prevention of oxidative allograft injury and its consequences.
    Land WG
    Transplant Rev (Orlando); 2012 Apr; 26(2):88-102. PubMed ID: 22000661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll like receptors and acute allograft rejection.
    Goldstein DR
    Transpl Immunol; 2006 Dec; 17(1):11-5. PubMed ID: 17157206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individuality: the barrier to optimal immunosuppression.
    Kahan BD
    Nat Rev Immunol; 2003 Oct; 3(10):831-8. PubMed ID: 14523389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight dextran sulfate as complement inhibitor and cytoprotectant in solid organ and islet transplantation.
    Spirig R; Gajanayake T; Korsgren O; Nilsson B; Rieben R
    Mol Immunol; 2008 Oct; 45(16):4084-94. PubMed ID: 18722664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of innate and adaptive immunity on rejection and tolerance.
    Kim IK; Bedi DS; Denecke C; Ge X; Tullius SG
    Transplantation; 2008 Oct; 86(7):889-94. PubMed ID: 18852649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking innate to adaptive immunity through dendritic cells.
    Steinman RM
    Novartis Found Symp; 2006; 279():101-9; discussion 109-13, 216-9. PubMed ID: 17278389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing immunology of organ transplantation.
    Starzl TE; Demetris AJ; Murase N; Trucco M; Thomson AW; Rao AS
    Hosp Pract (1995); 1995 Oct; 30(10):31-4, 37-42. PubMed ID: 7593387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choosing between immunity and tolerance after transplantation.
    Samstein B
    Cell Immunol; 2007 Jul; 248(1):44-7. PubMed ID: 18028889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the innate immune system by the endogenous ligand hyaluronan.
    Shirali AC; Goldstein DR
    Curr Opin Organ Transplant; 2008 Feb; 13(1):20-5. PubMed ID: 18660702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Host immunosuppression in pathogenesis of sepsis and its clinical implication].
    Yao YM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):138-41. PubMed ID: 17376264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation blockade and its possible future use in clinical transplantation.
    Snanoudj R; de Préneuf H; Créput C; Arzouk N; Deroure B; Beaudreuil S; Durrbach A; Charpentier B
    Transpl Int; 2006 Sep; 19(9):693-704. PubMed ID: 16918529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Links between innate and cognate tumor immunity.
    Ghiringhelli F; Apetoh L; Housseau F; Kroemer G; Zitvogel L
    Curr Opin Immunol; 2007 Apr; 19(2):224-31. PubMed ID: 17303400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized immunosuppression: new strategies from pharmacokinetics, pharmacodynamics and pharmacogenomics.
    Chen G; Dong JH
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):332-8. PubMed ID: 16109511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes.
    Wen H; Schaller MA; Dou Y; Hogaboam CM; Kunkel SL
    J Leukoc Biol; 2008 Mar; 83(3):439-46. PubMed ID: 17991763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: promises and difficulties.
    Ehser S; Chuang JJ; Kleist C; Sandra-Petrescu F; Iancu M; Wang D; Opelz G; Terness P
    Hum Immunol; 2008 Mar; 69(3):165-73. PubMed ID: 18396208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-regulatory cells-what relationship with immunosuppressive agents?
    Wekerle T
    Transplant Proc; 2008 Dec; 40(10 Suppl):S13-6. PubMed ID: 19100898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.